A Study of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT06526182 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06526182
- Sponsor
- Almirall, S.A.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-03
- Primary completion
- 2027-04-25
- Enrollment
- 520
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.